نتایج جستجو برای: coartem

تعداد نتایج: 83  

Journal: :Bangladesh Medical Research Council bulletin 2013
R Samad M R Rahman E B Yunus M A Hussain S M Arif M N Islam S A M M A Hafiz M M Hossain M A Faiz

National Malaria Control Program (NMCP) of Bangladesh has introduced Artemisinin Based Combination (ACT), Coartem(R) (Artemether-Lumefantrine (AL), fixed dose combination, in the confirmed cases of uncomplicated P. falciparum malaria since 2004. Despite the reduction of mortality due to malaria, the development and spread of anti-malarial drug resistance wordwide posing a threat to the health s...

2012
Leah Mwai Abdi Diriye Victor Masseno Steven Muriithi Theresa Feltwell Jennifer Musyoki Jacob Lemieux Avi Feller Gunnar R. Mair Kevin Marsh Chris Newbold Alexis Nzila Céline K. Carret

The combination therapy of the Artemisinin-derivative Artemether (ART) with Lumefantrine (LM) (Coartem®) is an important malaria treatment regimen in many endemic countries. Resistance to Artemisinin has already been reported, and it is feared that LM resistance (LMR) could also evolve quickly. Therefore molecular markers which can be used to track Coartem® efficacy are urgently needed. Often, ...

Journal: :PloS one 2016
Desalegn Nega Ashenafi Assefa Hussein Mohamed Hiwot Solomon Adugna Woyessa Yibeltal Assefa Amha Kebede Moges Kassa

BACKGROUND As per the WHO recommendation, the development of resistance by P. falciparum to most artemisinin combination therapies (ACTs) triggered the need for routine monitoring of the efficacy of the drugs every two years in all malaria endemic countries. Hence, this study was carried out to assess the therapeutic efficacy of Artemether-Lumefantrine (Coartem®) in treating the uncomplicated f...

2016
Feven Wudneh Ashenafi Assefa Desalegn Nega Hussien Mohammed Hiwot Solomon Tadesse Kebede Adugna Woyessa Yibeltal Assefa Amha Kebede Moges Kassa

PURPOSE Following the increased Plasmodium falciparum resistance to chloroquine and sulfadoxine/pyrimethamine, Ethiopia adopted artemether/lumefantrine (AL) as the first-line treatment for uncomplicated P. falciparum in 2004. According to the recommendation of the World Health Organization, this study was carried out for regular monitoring of the efficacy of AL in treating the uncomplicated P. ...

2009
D.M. Kiboi B.N. Irungu B. Langat S. Wittlin R. Brun J. Chollet O. Abiodun J.K. Nganga V.C.S. Nyambati G.M. Rukunga A. Bell A. Nzila

We have selected piperaquine (PQ) and lumefantrine (LM) resistant Plasmodium berghei ANKA parasite lines in mice by drug pressure. Effective doses that reduce parasitaemia by 90% (ED(90)) of PQ and LM against the parent line were 3.52 and 3.93 mg/kg, respectively. After drug pressure (more than 27 passages), the selected parasite lines had PQ and LM resistance indexes (I(90)) [ED(90) of resista...

Journal: :iranian journal of public health 0
jared otieno ogolla dept. of public health, school of health sciences, mount kenya university, eldoret, kenya. samuel omulando ayaya christina agatha otieno

this study sought to determine the level of adherence to coartem© in the routine treatment of uncomplicated malaria among children under the age of five years in nyando district, kenya.seventy-three children below the age of five years with microscopically confirmed uncomplicated plasmodium falciparum malaria and prescribed coartem(®) during the normal outpatient department hours were included ...

Journal: :Saudi medical journal 2013
Alexis Nzila Ibrahim Al-Zahrani

Current malaria treatments are based on the use of artemisinin based combinations. In the Kingdom of Saudi Arabia, the combination of pyrimethamine/sulfadoxine/artesunate is the first line of treatment of uncomplicated malaria, while lumefantrine/artemether (Coartem) is used as a second option. The treatment of severe malaria rests on the use of quinine or artesunate. In Saudi Arabia, most case...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید